Convergence Investment Partners, LLC Emergent Bio Solutions Inc. Transaction History

Convergence Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 23, 2019	SELL	$39.92 - $53.86 $147,743 - $199,335	-3,701 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$48.23 - $66.16 $183,611 - $251,871	-3,807 Reduced 50.71%	3,701 $187,000
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $65,921 - $86,789	-1,185 Reduced 13.63%	7,508 $445,000
Q3 2018 Nov 13, 2018	SELL	$52.05 - $66.51 $525,965 - $672,083	-10,105 Reduced 53.76%	8,693 $572,000
Q2 2018 Aug 07, 2018	SELL	$48.33 - $55.64 $3.04 Million - $3.5 Million	-62,982 Reduced 77.01%	18,798 $949,000
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $245,886 - $300,939	-5,533 Reduced 6.34%	81,780 $4.31 Million
Q4 2017 Jan 16, 2018	BUY	$37.77 - $47.75 $1.37 Million - $1.73 Million	36,247 Added 70.98%	87,313 $4.06 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $1.74 Million - $2.07 Million	51,066	51,066 $2.07 Million

158

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $561M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.